Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue homeostasis across metazoans, is highly conserved throughout evolution. The Notch receptor and its ligands are transmembrane proteins containing epidermal growth factor-like repeat sequences, typically nece...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Signal transduction and targeted therapy Ročník 9; číslo 1; s. 128 - 37
Hlavní autori: Shi, Qingmiao, Xue, Chen, Zeng, Yifan, Yuan, Xin, Chu, Qingfei, Jiang, Shuwen, Wang, Jinzhi, Zhang, Yaqi, Zhu, Danhua, Li, Lanjuan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London Nature Publishing Group UK 27.05.2024
Nature Publishing Group
Predmet:
631/67/1059
692/699/67/1857
Angiogenesis
Cancer
Cancer Research
Cancer therapies
Cell Biology
Cell fate
Chemoresistance
Clinical trials
Epithelial-Mesenchymal Transition - genetics
Homeostasis
Humans
Internal Medicine
Invasiveness
Malignancy
Medical innovations
Medicine
Medicine & Public Health
Metastases
Molecular Targeted Therapy
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Notch protein
Oncology
Pathology
Receptors, Notch - genetics
Receptors, Notch - metabolism
Review
Review Article
Signal transduction
Signal Transduction - genetics
Tumor cells
Tumor microenvironment
Tumor Microenvironment - drug effects
Tumor Microenvironment - genetics
Tumor suppressor genes
Tumors
ISSN:2059-3635, 2095-9907, 2059-3635
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue homeostasis across metazoans, is highly conserved throughout evolution. The Notch receptor and its ligands are transmembrane proteins containing epidermal growth factor-like repeat sequences, typically necessitating receptor-ligand interaction to initiate classical Notch signaling transduction. Accumulating evidence indicates that the Notch signaling pathway serves as both an oncogenic factor and a tumor suppressor in various cancer types. Dysregulation of this pathway promotes epithelial-mesenchymal transition and angiogenesis in malignancies, closely linked to cancer proliferation, invasion, and metastasis. Furthermore, the Notch signaling pathway contributes to maintaining stem-like properties in cancer cells, thereby enhancing cancer invasiveness. The regulatory role of the Notch signaling pathway in cancer metabolic reprogramming and the tumor microenvironment suggests its pivotal involvement in balancing oncogenic and tumor suppressive effects. Moreover, the Notch signaling pathway is implicated in conferring chemoresistance to tumor cells. Therefore, a comprehensive understanding of these biological processes is crucial for developing innovative therapeutic strategies targeting Notch signaling. This review focuses on the research progress of the Notch signaling pathway in cancers, providing in-depth insights into the potential mechanisms of Notch signaling regulation in the occurrence and progression of cancer. Additionally, the review summarizes pharmaceutical clinical trials targeting Notch signaling for cancer therapy, aiming to offer new insights into therapeutic strategies for human malignancies.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2059-3635
2095-9907
2059-3635
DOI:10.1038/s41392-024-01828-x